© 2007 American Public Health Association DOI: 10.2105/AJPH.2005.083287
Jef L. Leroy and Stefano M. Bertozzi are with the Mexican National Institute of Public Health (Instituto Nacional de Salud Publica), Cuernavaca, Mexico. Stefano M. Bertozzi is also with the Center for Economics Research and Education, Mexico City, and the University of California, Berkeley. Jean-Pierre Habicht and Gretel Pelto are with the Division of Nutritional Sciences, Cornell University, Ithaca, NY. Correspondence: Requests for reprints should be sent to Jef L. Leroy, PhD, MSc, Instituto Nacional de Salud Publica, Avenida Universidad No. 655, Col. Sta. María Ahuacatitlán, Cuernavaca, Morelos, Mexico 62508 (e-mail: jleroy{at}correo.insp.mx).
ABSTRACT
We determined the proportion of research on childhood mortality directed toward better medical technology (i.e., by improving old technology or creating new technology) compared with research on technology delivery and utilization. We also estimated mortality reductions from a research-funding strategy focusing primarily on developing technology compared with one that also focused on delivery and utilization. Ninety-seven percent of grants were for developing new technologies, which could reduce child mortality by 22%. This reduction is one third of what could be achieved if existing technologies were fully utilized. There is a serious discrepancy between current research and the research needed to save childrens lives. In addition to increased research on the efficacy of treatment, there is an even greater need for increased research on delivery and use of technology. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||